サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1226814

中東・アフリカのカルボキシセラピーの2028年までの市場予測-地域別分析-タイプ別、アプリケーション別、エンドユーザー別

Middle East & Africa Carboxy Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Tabletop, Portable, and Others), Application, and End User (Hospitals, Aesthetic Clinics, and Wellness Center)
出版日: | 発行: The Insight Partners | ページ情報: 英文 99 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
中東・アフリカのカルボキシセラピーの2028年までの市場予測-地域別分析-タイプ別、アプリケーション別、エンドユーザー別
出版日: 2023年01月30日
発行: The Insight Partners
ページ情報: 英文 99 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中東・アフリカのカルボキシセラピー市場は、2022年の363万米ドルから2028年には709万米ドルに成長すると予測されています。2022年から2028年までのCAGRは11.8%と推定されています。

新興国の未開発のポテンシャルが中東・アフリカのカルボキシ療法市場を牽引する

カルボキシセラピーは、炭酸ガスを注射薬として使用するものです。皮膚科学、美容医学、アンチエイジング医学の分野で最も使用されている治療法の1つであり、その応用分野は拡大しています。この治療法がここ数年で普及し始めたため、治療に使用される機器も大きく発展してきました。従来の治療器はペン型であり、小型であるがゆえに重く、長時間の施術には不向きでした。そのため、洗練された使いやすいデバイスが開発されるようになりました。新興国市場の大手企業は、流通網の拡大や生産能力の増強により、市場への浸透を図っています。数カ国の新興市場は、今後数年間、主要なカルボキシセラピー機器メーカーに潜在的な成長機会を提供すると予想されます。これは、これらの国々における患者数の多さ、美容需要の増加、アンチエイジング治療への関心の高まり、可処分所得の増加、ヘルスケアインフラの改善、医療観光の増加などに起因しています。新興国におけるライフサイエンスおよび健康研究への高い投資は、これらの国々の技術を向上させる上で重要な役割を担っています。このような要因が、カルボキシセラピーの採用への傾倒を後押ししています。

中東・アフリカの概要

中東・アフリカのカルボキシセラピー市場は、サウジアラビア、南アフリカ、UAE、その他中東・アフリカに区分されます。サウジアラビアは、膨大な人口と非侵襲的な美容施術の採用増加により、中東・アフリカで最も急成長している市場の1つです。サウジアラビアでは、老年人口の増加により美容施術の需要が高まっています。サウジアラビアの人口高齢化に関する報告書によると、サウジアラビアにおける60歳以上の高齢者の割合は、2050年末には総人口4000万人のうち25％になると推測されています。また、80歳以上の高齢者は同時期に総人口の4％に当たる160万人に達すると予想されています。老化を遅らせる治療法を発見するための研究の高まりと投資の増加が、同国の市場を牽引しています。例えば、2022年6月、サウジアラビア王室はHevolution Foundationという非営利団体を立ち上げ、石油資産のうち年間最大10億米ドルを費やして老化の生物学を探求し、人々が健康に生きる年数を延ばす方法を見出す計画です。美容整形は、医療分野で最も多く行われている施術のひとつです。そのような方法は、ますます人気が高まっています。カルボキシセラピーの有効性や安全性を検討するために、さまざまな研究が行われています。例えば、2019年5月には、異なる作用機序で機能するクマに対する3つの異なる治療様式の有効性と安全性を評価するために、カルボキシセラピーvsケミカルピーリング vsメソセラピーの比較研究が実施されました。その結果、3つの治療法すべてが眼窩周囲の色素沈着の軽減に有効であると結論づけられました。しかし、メソセラピーは他の治療法に比べて色素沈着が有意に改善され、患者満足度も高かったです。インターネットの高尚な普及と世界の美の基準の変化が、国内での美容施術の需要を高めています。インターネットの力とともに、ソーシャルメディアは多くの人々の生活の根幹をなすものとなっています。

中東・アフリカカルボキシセラピー市場の収益と2028年までの予測（US$Million）

中東・アフリカのカルボキシセラピー市場のセグメンテーション

中東・アフリカのカルボキシセラピー市場は、タイプ、アプリケーション、エンドユーザー、国に区分されます。

タイプに基づき、中東・アフリカのカルボキシセラピー市場は、卓上型、ポータブル型、その他に区分されます。2022年、中東・アフリカのカルボキシセラピー市場では、卓上型セグメントが最大のシェアを記録しました。

アプリケーションに基づき、中東・アフリカのカルボキシセラピー市場は、美容医療、皮膚科学、血管学、婦人科学、整形外科およびリウマチ学、スポーツ医学、およびその他に区分されます。2022年、美容医療セグメントは中東・アフリカのカルボキシセラピー市場で最大のシェアを記録しました。美容医療セグメントは、セルライト、ストレッチマーク、脱毛症、目の下のクマに細分化されます。

エンドユーザーに基づき、中東・アフリカのカルボキシセラピー市場は、病院、美容クリニック、ウェルネスセンターに区分されます。2022年、中東・アフリカのカルボキシセラピー市場では、病院セグメントが最大のシェアを記録しました。

国別に見ると、中東・アフリカのカルボキシセラピー市場は、サウジアラビア、南アフリカ、UAE、その他中東・アフリカに区分されます。2022年には、その他中東とアフリカのセグメントが、中東・アフリカのカルボキシセラピー市場で最大のシェアを記録しました。

Carbossiterapia Italiana、DTA Medical、Kastner-Praxisbedarf、MBE Medical Division、Mezopharma、Nick Fanavaran Plasma Companyなどは、中東・アフリカのカルボキシ療法市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 カルボキシセラピー市場-重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 カルボキシセラピー市場- 市場情勢

  • 中東・アフリカのPEST分析
  • 専門家の見解

第5章 中東・アフリカのカルボキシセラピーの市場- 主要な市場力学

  • 市場促進要因
    • 非侵襲的な美容施術の利用拡大
    • 高齢者人口の増加に伴うアンチエイジング治療への需要の高まり
  • 市場抑制要因
    • 炭素療法に関連する規制方針と安全性への懸念
  • 市場機会
    • 新興国における未開発のポテンシャル
  • 今後の動向
    • 応用分野の拡大
  • インパクトのある分析

第6章 カルボキシセラピー市場-中東・アフリカ分析

  • 中東・アフリカのカルボキシセラピーの市場収益と予測・分析

第7章 中東・アフリカのカルボキシセラピーの市場分析：タイプ別

  • 中東・アフリカカルボキシセラピーの市場収益シェア：タイプ別（2021年・2028年）
  • テーブルトップ型
  • 携帯型
  • その他

第8章 中東・アフリカのカルボキシセラピーの市場分析：用途別

  • 中東・アフリカカルボキシセラピー：用途別市場収益シェア（2021年・2028年）
  • 美容医療
  • 皮膚科
  • 婦人科領域
  • 血管学
  • 整形外科およびリウマチ科
  • スポーツ医学
  • その他

第9章 中東・アフリカカルボキシセラピー市場：エンドユーザー別

  • 中東・アフリカカルボキシセラピー市場：エンドユーザー別、2021年・2028年（%）
  • 病院
  • エステティッククリニック
  • ウェルネスセンター

第10章 中東・アフリカのカルボキシセラピーの市場：国別分析

第11章 業界情勢

  • 開発状況

第12章 企業プロファイル

  • DTA Medical
  • Carbossiterapia Italiana
  • Kastner-Praxisbedarf
  • Mezopharma
  • MBE Medical Division
  • Nick Fanavaran Plasma Company

第13章 付録

図表

List Of Tables

  • Table 1. MEA: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
  • Table 2. UAE Carboxy Therapy Market Revenue and Forecasts to 2028, By Type (US$ Million)
  • Table 3. UAE Carboxy Therapy Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 4. UAE Carboxy Therapy Market Revenue and Forecasts to 2028, For Aesthetic Medicine by Application (US$ Million)
  • Table 5. UAE Carboxy Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million).
  • Table 6. Saudi Arabia Carboxy Therapy Market Revenue and Forecasts to 2028, By Type (US$ Million)
  • Table 7. Saudi Arabia Carboxy Therapy Market Revenue and Forecasts to 2028, By Application(US$ Million)
  • Table 8. Saudi Arabia Carboxy Therapy Market Revenue and Forecasts to 2028, For Aesthetic Medicine by Application (US$ Million)
  • Table 9. Saudi Arabia Carboxy Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million).
  • Table 10. South Africa Carboxy Therapy Market Revenue and Forecasts to 2028, By Type (US$ Million).
  • Table 11. South Africa Carboxy Therapy Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 12. South Africa Carboxy Therapy Market Revenue and Forecasts to 2028, By Aesthetic Medicine by Application (US$ Million)
  • Table 13. South Africa Carboxy Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million).
  • Table 14. Rest of Middle East & Africa Carboxy Therapy Market Revenue and Forecasts to 2028, By Type (US$ Million)
  • Table 15. Rest of Middle East & Africa Carboxy Therapy Market Revenue and Forecasts to 2028, By Application (US$ Million)
  • Table 16. Rest of Middle East & Africa Carboxy Therapy Market Revenue and Forecasts to 2028, For Aesthetic Medicine by Application (US$ Million)
  • Table 17. Rest of Middle East & Africa Carboxy Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million).
  • Table 18. Developments Done by Companies
  • Table 19. Glossary of Terms, Carboxy Therapy Market

List Of Figures

  • Figure 1. MEA Carboxy Therapy Market Segmentation
  • Figure 2. MEA Carboxy Therapy Market, By Country
  • Figure 3. MEA Carboxy Therapy Market Overview
  • Figure 4. MEA Carboxy Therapy Market, By Type
  • Figure 5. MEA Carboxy Therapy Market, By Country
  • Figure 6. Middle East & Africa PEST Analysis
  • Figure 7. MEA Impact Analysis: Carboxy Therapy Market
  • Figure 8. MEA Carboxy Therapy Market- Revenue Forecast and Analysis - 2019- 2028
  • Figure 9. MEA Carboxy Therapy Market Revenue Share, by Type (2021 & 2028)
  • Figure 10. MEA Tabletop: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. MEA Portable: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. MEA Others: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. MEA Carboxy Therapy Market Revenue Share, by Application (2021 & 2028)
  • Figure 14. MEA Aesthetic Medicine: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. MEA Cellulite: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. MEA Stretch Marks: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. MEA Alopecia: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. MEA Dark Under-Eye Circles: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. MEA Dermatology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. MEA Gynecology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. MEA Angiology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. MEA Orthopedics and Rheumatology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. MEA Sports Medicine: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. MEA Others: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. MEA Carboxy Therapy Market, by End User, 2021 and 2028 (%)
  • Figure 26. MEA Hospitals: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. MEA Aesthetic Clinics: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. MEA Wellness Center: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Middle East & Africa Carboxy Therapy Market, by Country- Revenue 2021 (US$ Million)
  • Figure 30. Middle East & Africa Carboxy Therapy Market Revenue and Forecast to 2028, by Country (%)
  • Figure 31. UAE: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Saudi Arabia: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. South Africa: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Rest of Middle East & Africa: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00027996

The Middle East & Africa carboxy therapy market is expected to grow from US$ 3.63 million in 2022 to US$ 7.09 million by 2028. It is estimated to grow at a CAGR of 11.8% from 2022 to 2028.

Untapped Potential of Emerging Economies is Driving the Middle East & Africa Carboxy Therapy Market

Carboxy therapy involves the use of carbon dioxide gas as injectables. Its increasing application areas made it one of the most used treatment modalities in dermatology, aesthetic medicine, and anti-aging medicine. As the therapy started gaining traction in the past few years, there has been significant development in the devices used for the treatments. Conventional devices are in the form of pens which are small in size but heavy in nature which makes them difficult to hold during long sessions. This led to the development of devices that are sophisticated and easy to use. Leading market players are increasing their penetration across developing markets by expanding their distribution networks and augmenting their production capabilities. Emerging markets in several countries are expected to offer potential growth opportunities for key carboxy therapy device manufacturers in the years to come. This can be attributed to the large patient population, increase in demand for aesthetics, rise in interest in anti-aging treatments, increase in disposable income, improved healthcare infrastructure, and rise in medical tourism in these countries. High investments in life science and health research in emerging countries play a key role in upgrading the technologies in these countries. This factor, in turn, supports the inclination toward the adoption of carboxy therapy.

Middle East & Africa Overview

The Middle East & Africa carboxy therapy market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia is one of the fastest-growing markets in the Middle East & Africa, driven by a huge population base and rise in the adoption of non-invasive aesthetic procedures. The demand for aesthetic procedures in Saudi Arabia is increasing due to the rising geriatric population. As per the Population Aging in Saudi Arabia report, the percentage of people in Saudi Arabia aged 60 or more is speculated to be 25% of the total population of 40 million by the end of 2050. Also, the number of people aged 80 or more is expected to reach 1.6 million, or 4% of the total population, in the same period. Growing studies and increasing investments in discovering treatments to slow aging are driving the market in the country. For instance, in June 2022, the Saudi royal family started a not-for-profit organization called the Hevolution Foundation that plans to spend up to US$ 1 billion a year of its oil wealth to explore the biology of aging and find ways to extend the number of years people live in good health. Aesthetic procedures are among the most performed procedures in the medical field. Such methods are becoming increasingly popular. Various studies are being conducted to study the efficacy and safety of carboxytherapy. For instance, in May 2019, a comparative study of carboxy therapy vs chemical peeling vs mesotherapy was conducted to assess the efficacy and safety of 3 different modalities of treatment for dark circles that function via different modes of action. The study concluded that all 3 treatment modalities were effective in the reduction of periorbital pigmentation. However, mesotherapy showed a significant improvement in pigmentation and a higher level of patient satisfaction compared to the other types of treatment. Lofty penetration of the internet and change in global beauty standards have increased the demand for aesthetic procedures in the country. Along with the power of the internet, social media has become a fundamental part of many people's lives.

Middle East & Africa Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Carboxy Therapy Market Segmentation

The Middle East & Africa carboxy therapy market is segmented into type, application, end user, and country.

Based on type, the Middle East & Africa carboxy therapy market is segmented into tabletop, portable, and others. In 2022, the tabletop segment registered a largest share in the Middle East & Africa carboxy therapy market.

Based on application, the Middle East & Africa carboxy therapy market is segmented into aesthetic medicine, dermatology, angiology, gynecology, orthopedics and rheumatology, sports medicine, and others. In 2022, the aesthetic medicine segment registered a largest share in the Middle East & Africa carboxy therapy market. The aesthetic medicine segment is subsegmented into cellulite, stretch marks, alopecia, and dark under-eye circles.

Based on end user, the Middle East & Africa carboxy therapy market is segmented into hospitals, aesthetic clinics, and wellness center. In 2022, the hospitals segment registered a largest share in the Middle East & Africa carboxy therapy market.

Based on country, the Middle East & Africa carboxy therapy market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. In 2022, the Rest of Middle East & Africa segment registered a largest share in the Middle East & Africa carboxy therapy market.

Carbossiterapia Italiana; DTA Medical; Kastner-Praxisbedarf; MBE Medical Division; Mezopharma; and Nick Fanavaran Plasma Company are among the leading companies operating in the Middle East & Africa carboxy therapy market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa carboxy therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa carboxy therapy market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the carboxy therapy market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 MEA Carboxy Therapy Market - By Type
    • 1.3.2 MEA Carboxy Therapy Market - By Application
    • 1.3.3 MEA Carboxy Therapy Market - By End User
    • 1.3.4 MEA Carboxy Therapy Market - By Country

2. Carboxy Therapy Market- Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. MEA Carboxy Therapy Market - Market Landscape

  • 4.1 Overview
  • 4.2 MEA PEST Analysis
  • 4.3 Expert Opinion

5. MEA Carboxy Therapy Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Uptake of Non-invasive Aesthetic Procedures
    • 5.1.2 Increasing Demand for Anti-aging Treatments Along with Surge in Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Regulatory Policies and Safety Concerns Associated with Carbon Therapy
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Potential of Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Increase in Application Areas
  • 5.5 Impact Analysis

6. Carboxy Therapy Market- MEA Analysis

  • 6.1 MEA Carboxy Therapy Market Revenue Forecast and Analysis

7. MEA Carboxy Therapy Market Analysis - By Type

  • 7.1 Overview
  • 7.2 MEA Carboxy Therapy Market Revenue Share, by Type (2021 & 2028)
  • 7.3 Tabletop
    • 7.3.1 Overview
    • 7.3.2 Tabletop: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Portable
    • 7.4.1 Overview
    • 7.4.2 Portable: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)

8. MEA Carboxy Therapy Market Analysis - By Application

  • 8.1 Overview
  • 8.2 MEA Carboxy Therapy Market Revenue Share, by Application (2021 & 2028)
  • 8.3 Aesthetic Medicine
    • 8.3.1 Overview
    • 8.3.2 Aesthetic Medicine: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.1 Cellulite
        • 8.3.2.1.1 Overview
        • 8.3.2.1.2 Cellulite: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.2 Stretch Marks
        • 8.3.2.2.1 Overview
        • 8.3.2.2.2 Stretch Marks: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.3 Alopecia
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Alopecia: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.4 Dark Under-Eye Circles
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Dark Under-Eye Circles: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Dermatology
    • 8.4.1 Overview
    • 8.4.2 Dermatology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Gynecology
    • 8.5.1 Overview
    • 8.5.2 Gynecology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Angiology
    • 8.6.1 Overview
    • 8.6.2 Angiology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Orthopedics and Rheumatology
    • 8.7.1 Overview
    • 8.7.2 Orthopedics and Rheumatology: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Sports Medicine
    • 8.8.1 Overview
    • 8.8.2 Sports Medicine: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: Carboxy Therapy Market- Revenue and Forecast to 2028 (US$ Million)

9. MEA Carboxy Therapy Market - By End User

  • 9.1 Overview
  • 9.2 MEA Carboxy Therapy Market, by End User, 2021 and 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Aesthetic Clinics
    • 9.4.1 Overview
    • 9.4.2 Aesthetic Clinics: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Wellness Center
    • 9.5.1 Overview
    • 9.5.2 Wellness Center: Carboxy Therapy Market - Revenue and Forecast to 2028 (US$ Million)

10. MEA Carboxy Therapy Market - by Country Analysis

  • 10.1 Overview
    • 10.1.1 Middle East & Africa Carboxy Therapy Market Revenue and Forecast to 2028, by Country (%)
      • 10.1.1.1 UAE: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 UAE: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 UAE: Carboxy Therapy Market Revenue and Forecasts to 2028, By Type (US$ Million)
        • 10.1.1.1.4 UAE: Carboxy Therapy Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.1.1.1.4.1 UAE: Carboxy Therapy Market Revenue and Forecasts to 2028, For Aesthetic Medicine by Application (US$ Million)
        • 10.1.1.1.5 UAE: Carboxy Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 10.1.1.2 Saudi Arabia: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Saudi Arabia: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Saudi Arabia: Carboxy Therapy Market Revenue and Forecasts to 2028, By Type (US$ Million)
        • 10.1.1.2.4 Saudi Arabia: Carboxy Therapy Market Revenue and Forecasts to 2028, By Application(US$ Million)
        • 10.1.1.2.4.1 Saudi Arabia: Carboxy Therapy Market Revenue and Forecasts to 2028, For Aesthetic Medicine by Application (US$ Million)
        • 10.1.1.2.5 Saudi Arabia: Carboxy Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 10.1.1.3 South Africa: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 South Africa Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 South Africa: Carboxy Therapy Market Revenue and Forecasts to 2028, By Type (US$ Million)
        • 10.1.1.3.4 South Africa: Carboxy Therapy Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.1.1.3.4.1 South Africa: Carboxy Therapy Market Revenue and Forecasts to 2028, For Aesthetic Medicine by Application (US$ Million)
        • 10.1.1.3.5 South Africa: Carboxy Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)
      • 10.1.1.4 Rest of Middle East & Africa: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Rest of Middle East & Africa: Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 Rest of Middle East & Africa: Carboxy Therapy Market Revenue and Forecasts to 2028, By Type (US$ Million)
        • 10.1.1.4.4 Rest of Middle East & Africa: Carboxy Therapy Market Revenue and Forecasts to 2028, By Application (US$ Million)
        • 10.1.1.4.4.1 Rest of Middle East & Africa: Carboxy Therapy Market Revenue and Forecasts to 2028, For Aesthetic Medicine by Application (US$ Million)
        • 10.1.1.4.5 Rest of Middle East & Africa: Carboxy Therapy Market Revenue and Forecasts to 2028, By End User (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Developments
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 DTA Medical
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Carbossiterapia Italiana
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Kastner-Praxisbedarf
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Mezopharma
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 MBE Medical Division
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Nick Fanavaran Plasma Company
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms, Carboxy Therapy Market